NUCLIDIUM
Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term survival can be significantly improved.
NUCLIDIUM
Industry:
Health Care Medical
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.nuclidium.com
Total Employee:
1+
Status:
Active
Total Funding:
2.4 M CHF
Investors List
European Innovation Council
European Innovation Council investment in Grant - Nuclidium
Official Site Inspections
http://www.nuclidium.com
- Host name: sh20024.ispgateway.de
- IP address: 92.205.54.255
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "Nuclidium"
Nuclidium – Best-in-class Copper Radiotheranostics
NUCLIDIUM’s mission is to provide personalised therapy for cancer patients at every stage of their disease. Our flexible CuTrace™ platform combines copper radiometals with a variety of …See details»
About Us - Nuclidium
NUCLIDIUM’s vision is to address the unmet need in cancer medicine by providing personalised treatment options for cancer patients at every stage of their disease to improve long-term …See details»
NUCLIDIUM and PharmaLogic Form Strategic Partnership for …
PharmaLogic - Radiopharmacy
By combining copper radiometals with highly specific cancer-targeting molecules, NUCLIDIUM's theranostic approach aims to offer innovative diagnostic and therapeutic treatments for …See details»
Nuclidium - The Org
Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately.See details»
NUCLIDIUM AG - LinkedIn
We are a diverse and interdisciplinary team focused on changing precision radio-oncology for the better to deliver a true benefit to cancer patients. http://nuclidium.com. Biotechnology...See details»
Nuclidium - Crunchbase Company Profile & Funding
Contact Email info@nuclidium.com Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term …See details»
NUCLIDIUM and PharmaLogic Form Strategic …
May 15, 2023 · By combining copper radiometals with highly specific cancer-targeting molecules, NUCLIDIUM’s theranostic approach aims to offer innovative diagnostic and therapeutic treatments for patients...See details»
Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to …
May 22, 2024 · NUCLIDIUM is advancing a unique pipeline of targeted copper-based radiopharmaceuticals leveraging isotopes 61 Cu and 67 Cu. Its innovative platform facilitates a …See details»
Technology – Nuclidium
Our proprietary CuTrace™ platform utilises the unique properties of copper radionuclides in combination with tumour-specific molecules to create therapeutic and diagnostic pairs with an improved safety and efficacy profile, favourable …See details»
Nuclidium Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Nuclidium. Use the PitchBook Platform to explore the full profile.See details»
Leila Jaafar - CEO and Founder at Nuclidium - The Org
Leila Jaafar has an extensive work experience. Leila is currently the CEO and Founder of NUCLIDIUM AG since 2021. Prior to this, they were the CEO and Founder of Swiss Nuclides …See details»
NUCLIDIUM and PharmaLogic Form Strategic Partnership for …
May 15, 2023 · By combining copper radiometals with highly specific cancer-targeting molecules, NUCLIDIUM's theranostic approach aims to offer innovative diagnostic and therapeutic …See details»
NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board
Nov 20, 2024 · NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony Rosenberg as Chairman of the Board, bringing over 40 years of …See details»
NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board
Nov 20, 2024 · Basel, Switzerland, November 20, 2024 – NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony Rosenberg as …See details»
Nuclidium - Company Profile - Tracxn
1 day ago · Developer of radiopharmaceuticals for the treatment of cancer. The company is developing copper-based therapeutics and companion diagnostics which include NuriPro for …See details»
NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board
Nov 20, 2024 · BASEL, Switzerland, November 20, 2024 -- (BUSINESS WIRE)-- NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony …See details»
Nuclidium AG – Swiss Biotech
To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.See details»
News - Nuclidium
Mar 8, 2024 · The European Innovation Council (EIC) has awarded Nuclidium with its Accelerator grant of €2,5 million to develop novel, broadly available Copper-based PET tracers for the …See details»
Nuclidium - Overview, News & Similar companies | ZoomInfo.com
Oct 21, 2024 · View Nuclidium (www.nuclidium.com) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»